Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Performance of the AFGen1 Device Over a 7-day Period

NCT05295056 is registered in ClinicalTrials.gov with TriVirum, Inc. as lead sponsor.

NCT NCT05295056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05295056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Performance of the AFGen1 Device Over a 7-day Period
Lead sponsor
TriVirum, Inc.
Phase
Observational
Overall status
Completed
Start date
May 12, 2022
Completion date
August 25, 2023
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

afib, arrhythmia atrial, arrhythmias paroxysmal, arrhythmias, cardiac, atrial fibrillation, irregular heart beat, paroxysmal atrial fibrillation